| 1. Domain | 1.1 Scope of the Domain | Boundaries | The range of phenomena the science includes and excludes. | Studies biochemical processes as they occur inside living cells: molecular interactions, pathways, compartmentalization, signal handling, and emergent biochemical behavior; excludes isolated in-vitro biochemical processes lacking cellular context. |
| | Scale | The spatial, temporal, or organizational level at which the science operates (e.g., quantum, cellular, social, cosmic). | Operates from molecular interactions (protein–protein, enzyme–substrate) to organelle-level biochemistry (mitochondria, ER, lysosomes), whole-cell metabolic flux, and cell–cell biochemical communication. |
| 1.2 Ontological Commitments | Entities | The kinds of things assumed to exist within the domain (particles, organisms, agents, fields, etc.). | Organelles, metabolites, enzymes, structural proteins, membranes, lipids, transporters, chaperones, cytoskeletal components, signaling molecules, vesicles, proton gradients, reactive oxygen species, quality-control machinery. |
| | Properties | The fundamental attributes these entities possess (mass, charge, genotype, preference, etc.). | Concentration, localization, turnover rate, binding affinity, membrane potential, pH of compartments, redox state, metabolite flux, viscosity, crowding, ionic strength, macromolecular interactions, structural stability. |
| | Categories | The basic ontological types used to classify domain elements (substances, processes, relations, structures). | Organelles (mitochondria, ER, Golgi, lysosomes), cytoskeletal systems, trafficking pathways, metabolic modules, signaling modules, degradation systems (proteasome/autophagy), membrane-transport categories. |
| 1.3 State-Variables | Variables | The measurable or definable properties that describe system conditions. | Compartment-specific pH, redox potential, ion gradients (Ca²⁺, H⁺, Na⁺/K⁺), metabolite pool sizes, enzyme activity states, post-translational modification states, trafficking flux, signaling amplitude/duration. |
| | Parameterization | How variables encode and represent the system’s state. | States encoded via localization maps, concentration profiles, flux distributions, phosphorylation levels, redox ratios, membrane potential values, organelle-specific thermodynamic constraints, kinetic constants in vivo. |
| 1.4 Admissible Idealizations | Simplifications | Conceptual reductions used to make the domain tractable (point masses, rational agents, perfect gases). | Treating compartments as homogeneous, ignoring crowding, simplifying trafficking into linear routes, neglecting organelle dynamics, using single steady-state flux values, ignoring stochastic molecular noise. |
| | Validity Conditions | The limits and contexts in which idealizations hold or break down. | Valid in moderately stable steady states; break down during rapid signaling, stress, differentiation, apoptosis, organelle remodeling, extreme crowding, and local microdomain-specific biochemistry. |
| 1.5 Domain Assumptions | Structural Assumptions | Background ontological stances such as determinism, continuity, randomness, discreteness. | Cellular processes are governed by biochemical reaction networks; compartment boundaries strongly shape reactions; crowding and localization influence reaction kinetics; signal transduction reflects molecular interactions. |
| | Implicit Commitments | Unstated but necessary assumptions that shape the field’s conceptual structure. | Assumes definable compartments, stable molecular identities, consistent membrane-barrier behavior, meaningful reaction kinetics in vivo, and reliable mapping from molecular interactions to cellular-scale outcomes. |
| 1.6 Internal Coherence Requirements | Consistency | The demand that domain concepts do not contradict one another. | Requires coherence among metabolic flux patterns, signaling responses, traffic flow, redox state, organelle interactions, structural constraints, and cellular viability. |
| | Compatibility | The requirement that entities, variables, and assumptions fit together into a unified descriptive framework. | Demands alignment between molecular biochemistry, organelle function, signal transduction, gene expression, cellular physiology, and metabolic homeostasis within an integrated cellular framework. |
| 2. Evidence Layer | 2.1 Observable Phenomena | Observables | The aspects of the domain that can produce detectable signals accessible to measurement. | Fluorescence signals, organelle morphology changes, calcium spikes, membrane potential fluctuations, metabolite-level shifts, protein localization changes, vesicle trafficking, cytoskeletal dynamics, redox shifts, pH changes. |
| | Detection Limits | The boundaries of what can be resolved or sensed by current instruments or methods. | Limited by signal-to-noise, photobleaching, fluorophore brightness, temporal resolution, spatial resolution, antibody affinity, sensor saturation, metabolite instability, probe toxicity, and organelle crowding. |
| 2.2 Measurement Systems | Units | Standardized quantifications (meters, seconds, volts, decibels, dollars, etc.) necessary for consistent comparison. | Fluorescence intensity (a.u.), ion concentration (nM–mM), membrane potential (mV), pH units, metabolite levels (µM–mM), vesicle trafficking rate (events/s), redox ratio (NADH/NAD⁺), time (ms–hr). |
| | Instruments | Devices and tools (microscopes, spectrometers, sensors, surveys, detectors) used to produce measurements. | Confocal microscopes, super-resolution microscopes (STORM/STED/SIM), flow cytometers, live-cell fluorescence systems, FRET microscopes, FRAP rigs, Seahorse analyzers, mass spectrometers, EM, patch-clamp systems, microfluidic cell-tracking devices. |
| 2.3 Operational Definitions | Definitions | Terms defined by specific measurement procedures, ensuring empirical clarity. | Localization defined by fluorescence distribution; organelle identity by marker-protein labeling; trafficking rate by event frequency; Ca²⁺ spikes by sensor intensity thresholds; membrane potential by patch-clamp or voltage-sensitive dyes; redox state by fluorescence lifetime. |
| | Procedures | The explicit steps required to perform a measurement in a reproducible way. | Live-cell staining, transfection, CRISPR reporter integration, trafficking assays, FRAP/FLIP, calcium imaging protocols, patch-clamp setups, metabolic labeling, organelle isolation, fixation + staining workflows. |
| 2.4 Data Acquisition | Protocols | Formal processes for gathering data under controlled or standardized conditions. | Time-lapse imaging, high-speed Ca²⁺ imaging, multi-channel fluorescence, Z-stack acquisition, flow-cytometry runs, microfluidic time-series collection, organelle-specific metabolomics, single-cell redox/pH tracking. |
| | Sampling | Rules determining which subset of the domain is measured and how representative it is. | Multiple cells/fields, biological replicates, multi-timepoint sampling, region-of-interest sampling, organelle-specific sampling (mitochondria, ER, lysosomes), subcellular localization replicates, flow-sorting subsets. |
| 2.5 Data Character & Format | Data Types | The form raw evidence takes (time series, spectra, images, counts, qualitative records). | Fluorescence images, time-lapse movies, flow-cytometry plots, organelle tracking traces, pH/redox maps, live-cell FRET traces, patch-clamp current traces, metabolomic profiles, structural EM images. |
| | Resolution | The granularity or precision with which data is captured. | Determined by optical resolution (diffraction/ super-resolution), detector sensitivity, sampling frequency, probe response kinetics, signal-to-noise, calibration accuracy, and spatial crowding constraints. |
| 2.6 Reliability & Calibration | Calibration | Adjustment procedures ensuring instruments produce accurate results. | Fluorescence-intensity calibration, Ca²⁺ sensor calibration curves, pH/ratiometric dye calibration, redox-probe lifetime calibration, flow cytometer compensation, EM alignment, mass-spec metabolite standards, patch-clamp electrode calibration. |
| | Error Characterization | Identification and quantification of noise, uncertainty, bias, and measurement error. | Photobleaching, probe toxicity, autofluorescence, background noise, spectral bleed-through, segmentation errors, mislocalized markers, motion blur, fixation artifacts, cell-to-cell heterogeneity, and metabolic perturbation from probing. |
| 3. Structural Layer | 3.1 Patterns & Regularities | Laws / Relations | Stable, repeatable patterns governing how observables behave across conditions. | Conserved trafficking motifs, energy-dependent transport rules, cytoskeletal force–motion relationships, ion-homeostasis laws, compartment-specific pH/redox invariants, vesicle-budding/fusion patterns, metabolic–signaling coupling rules. |
| | Invariants | Quantities or properties that remain constant under transformations (symmetries, conservation laws). | Conserved organelle identities, invariant membrane asymmetry patterns, stable cytoskeletal polarity, constant Ca²⁺ oscillation motifs, conserved Rab GTPase trafficking codes, stable organelle-specific enzyme complements. |
| 3.2 Causal Architecture | Mechanisms | Underlying processes or structures that produce the observed regularities. | Vesicle budding/fusion (SNARE-mediated), cytoskeletal polymerization/depolymerization, proton pumping, ion gating, receptor internalization, membrane trafficking circuits, autophagy initiation, redox-buffer cycling, compartmental enzyme cascades. |
| | Pathways | Organized sequences of interactions forming a causal chain or network. | Endocytosis/exocytosis, ER–Golgi trafficking, lysosomal degradation, mitochondrial electron-transport/ATP synthesis, peroxisomal detox pathways, cytoskeletal remodeling cycles, Ca²⁺ signaling sequences, organelle–organelle contact-site exchange pathways. |
| 3.3 Theoretical Vocabulary | Concepts | Core terms that encode the domain’s structure (force, gene, equilibrium, field). | Compartmentalization, membrane potential, redox buffering, crowding effects, trafficking fidelity, metabolic compartmentation, cytoskeletal tension, signaling microdomains, organelle crosstalk, vesicle docking, Ca²⁺ microdomains. |
| | Classifications | Taxonomies, categories, or typologies that organize entities and relations. | Organelle types, trafficking pathways, cytoskeletal systems (actin, microtubules, IFs), membrane-transport categories (channels, carriers, pumps), degradation systems (proteasome, autophagy), metabolic zones, redox systems. |
| 3.4 Formal Representations | Equations | Mathematical constructs expressing laws, relations, or mechanisms. | Nernst equation for ion gradients, flux equations for trafficking, Michaelis–Menten steps inside cells, membrane-potential equations, Ca²⁺ diffusion equations, cytoskeletal polymerization kinetics, redox-buffer equilibrium equations. |
| | Models | Structured representations—mathematical, computational, or conceptual—used to predict and explain phenomena. | Compartmental metabolic models, vesicle trafficking models, Ca²⁺ signaling models, cytoskeletal dynamic-instability models, organelle interaction models, redox-state models, whole-cell biochemical network models. |
| 3.5 Idealized Structures | Simplified Models | Purposeful abstractions that capture essential dynamics while omitting irrelevant detail. | Perfectly well-mixed compartments, static organelle shapes, linear trafficking routes, no crowding, uniform diffusion, one-way transport, zero stochastic noise, stable membrane potentials without fluctuations. |
| | Limit Conditions | Regimes where specific models or approximations hold (classical vs. quantum, linear vs. nonlinear). | Break down in highly dynamic cells, polarized cells, extreme crowding, rapid signaling waves, organelle reshaping, local nanoscale gradients, stochastic fluctuations, phase-separated domains, and stress/damage responses. |
| 3.6 Integrative Frameworks | Unifying Theories | Higher-order structures that connect disparate laws or mechanisms under a coherent whole. | Integration of metabolism, signaling, transport, and structural dynamics into a unified cellular biochemical network; coupling organelle functions, ion-homeostasis, energy state, and cytoskeletal architecture into one coherent system. |
| | Interdisciplinary Links | Points where the theory connects to adjacent sciences or larger explanatory systems. | Connects to cell biology, biophysics, molecular biology, systems biology, physiology, immunology, neuroscience, and synthetic biology. |
| 4. Method Layer | 4.1 Inquiry Design | Experimental Design | Structured plans for manipulating variables to test causal claims. | Controlling nutrient supply, signaling stimuli, ion concentrations, membrane potentials, genetic perturbations, compartment-targeted probes, temperature, inhibitors, and environmental stresses to test causal biochemical responses in cells. |
| | Observational Design | Systematic approaches for gathering non-manipulated data (surveys, field studies, natural experiments). | Monitoring spontaneous trafficking events, organelle remodeling, basal redox drift, endogenous signaling fluctuations, unstimulated Ca²⁺ oscillations, passive pH shifts, and natural metabolic variability without imposed interventions. |
| 4.2 Testing & Validation | Hypothesis Testing | Procedures for evaluating whether evidence supports or contradicts specific claims. | Comparing predicted trafficking patterns, metabolic shifts, redox responses, ion fluxes, localization changes, and signaling dynamics with experimental data from fluorescence imaging, metabolomics, patch-clamp, and live-cell reporters. |
| | Replication | The requirement that results be independently reproducible under similar conditions. | Running replicate imaging sessions, multiple biological replicates, repeated metabolite extractions, multiple flow-cytometry runs, parallel microfluidic cultures, independent sensor calibrations, and repeated organelle-isolation experiments. |
| 4.3 Inference & Evaluation | Statistical Inference | Rules for drawing conclusions from noisy or incomplete data. | Calculating trafficking frequencies, diffusion coefficients, pH/redox shifts, ion-flux rates, signaling-kinetic parameters, organelle-interaction metrics, cell-to-cell variability statistics, and confidence intervals for biochemical-response behaviors. |
| | Model Comparison | Criteria (fit, simplicity, predictive accuracy, robustness) used to evaluate competing models. | Evaluating diffusion vs active-transport models, competing trafficking-circuit models, redox–buffer models, Ca²⁺ signaling models, metabolic-compartmentation models, and whole-cell kinetic frameworks. |
| 4.4 Error Management | Error Analysis | Identification and quantification of random and systematic errors. | Identifying photobleaching, background noise, fluorophore toxicity, segmentation errors, sensor saturation, drift in ion/proton gradients from probes, fixation artifacts, organelle fragmentation, and microfluidic flow artifacts. |
| | Bias Control | Methods for minimizing subjective, instrumental, or procedural biases. | Randomizing imaging fields, blinding sample identity, validating compartment-specific probes, controlling expression level of reporters, applying spectral unmixing, minimizing probe-induced perturbation, and using appropriate negative/positive controls. |
| 4.5 Adjudication & Revision | Peer Scrutiny | Collective evaluation of claims through critique, review, and debate. | Independent evaluation of imaging interpretations, trafficking-pathway assignments, metabolic-state claims, ion-flux quantification, organelle morphology classifications, and model-based cellular-behavior predictions. |
| | Theory Revision | Procedures for modifying, replacing, or discarding models based on new evidence. | Updating trafficking networks, revising compartment models, redefining cellular microdomains, adjusting metabolic–signaling coupling parameters, reassigning organelle roles, and refining Ca²⁺/redox dynamic models as new evidence arises. |
| 4.6 Integrity Conditions | Transparency | Requirements to disclose methods, data, assumptions, and limitations. | Full disclosure of imaging settings, probe concentrations, calibration curves, cell-handling conditions, segmentation algorithms, signal-processing workflows, genetic-perturbation methods, and normalization strategies. |
| | Ethical Standards | Norms ensuring responsible conduct in experimentation, data handling, and publication. | Honest reporting of phototoxicity effects, cell stress caused by probes, culture variability, negative results, ambiguous localization, and adherence to biosafety and ethical standards for live-cell and genetic manipulation work. |